Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient
Language English Country United States Media print-electronic
Document type Case Reports, Journal Article
PubMed
29800929
DOI
10.1016/j.carpath.2018.04.001
PII: S1054-8807(18)30040-1
Knihovny.cz E-resources
- Keywords
- Aortic valve replacement, Mucopolysaccharidosis type IVB, Progressive skeletal disease,
- MeSH
- Aortic Valve diagnostic imaging pathology physiopathology surgery transplantation MeSH
- Aortic Valve Stenosis diagnostic imaging etiology physiopathology surgery MeSH
- beta-Galactosidase genetics MeSH
- Bioprosthesis MeSH
- Biopsy MeSH
- Time Factors MeSH
- Heart Valve Prosthesis Implantation * instrumentation MeSH
- Echocardiography MeSH
- Calcinosis diagnostic imaging etiology physiopathology surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Mucopolysaccharidosis IV complications diagnosis genetics MeSH
- Mutation MeSH
- DNA Mutational Analysis MeSH
- Delayed Diagnosis MeSH
- Heart Valve Prosthesis MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- beta-Galactosidase MeSH
- GLB1 protein, human MeSH Browser
Mucopolysaccharidosis type IVB (MPS IVB) is a very rare lysosomal storage disorder characterized by skeletal dysplasia, hearing disorder, and cardiac valvular disease. Herein, we report an extremely rare manifestation of MPS IVB in a 60-year-old female patient who underwent a successful aortic valve replacement. The patient presented with mild coarse facial features, short stature, mild dyspnea, sternal protrusion, mild lumbar hyperlordosis, and waddling gait owing to bilateral femoral head necroses and bilateral arthrosis of the knees. The patient also suffered from dyspnea, NYHA II-III. Echocardiography revealed severe stenosis of a calcified aortic valve (AVA 0.67 cm2, AVAi 0.45 cm2/m2, PG max/mean 130/80 mmHg), left ventricular hypertrophy with predominant septal thickening (18 mm) and mild left ventricle outflow tract obstruction at rest, mild mitral valve regurgitation, and dilated ascending aorta (36 mm, 26.5 mm/m2). Dyspnea resolved after septal myectomy and replacement of the aortic valve with bioprosthesis. Excretion levels and spectrum of glycosaminoglycans (GAGs) in urine were normal in the patient. We confirmed the diagnosis of MPS IVB by identifying decreased beta-galactosidase activity in isolated leukocytes (6 nmol/h/mg; controls 95-272) and by molecular genetic analyses (c.438_440delTCT and c.817_818TG>CT mutations in the GLB1 gene). Primary lysosomal storage of glycosaminoglycans was detected in fibroblasts of the aortic valve. Additional pathologies included valvular fibrosis, calcification, neovascularization, and mild chronic inflammation. In conclusion, the diagnosis of MPS IVB should be considered in older patients with cardiac valvular disease and progressive skeletal abnormality even if urinary excretion levels of GAGs are normal.
References provided by Crossref.org
Misprocessing of α -Galactosidase A, Endoplasmic Reticulum Stress, and the Unfolded Protein Response
